Cargando…

Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer

High-level evidence supports adjuvant radiotherapy for rectal cancer. We examined the influence of sociodemographic factors on patterns of adjuvant radiotherapy for resected Stage II/III rectal cancer. Methods. Patients undergoing surgical resection for stage II/III rectal cancer were identified in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitzgerald, Timothy L., Zervos, Emmanuel, Wong, Jan H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808718/ https://www.ncbi.nlm.nih.gov/pubmed/24223589 http://dx.doi.org/10.1155/2013/408460

Ejemplares similares

Altered fractionation short-course radiotherapy for stage II-III rectal cancer: a retrospective study
por: Geinitz, Hans, et al.
Publicado: (2020)

Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer
por: Lu, Ning-Ning, et al.
Publicado: (2015)

The Survival Effect of Radiotherapy on Stage II/III Rectal Cancer in Different Age Groups: Formulating Radiotherapy Decision-Making Based on Age
por: Li, Yuqiang, et al.
Publicado: (2021)

Pelvic local recurrence as first relapse predicts prognosis for clinical stage II/III lower rectal cancer: A clinicopathological investigation
por: Uda, Shuji, et al.
Publicado: (2021)

Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy
por: Li, Qingguo, et al.
Publicado: (2015)

Comparative survival analysis of preoperative and postoperative radiotherapy in stage II-III rectal cancer on the basis of long-term population data
por: Lim, Yu Jin, et al.
Publicado: (2018)

Contemporary, national patterns of surgery after preoperative therapy for stage II/III rectal adenocarcinoma
por: Soriano, Celine, et al.
Publicado: (2022)

Staging rectal cancer: endoscopic ultrasound and pelvic MRI
por: Brown, Gina
Publicado: (2008)

Stage II/III Rectal Cancer Post-Treatment Surveillance Patterns of Care: A SEER- Medicare Study
por: Chioreso, Catherine, et al.
Publicado: (2021)

Age-dependent response to multimodal therapy for stage II-III rectal cancer
por: Delitto, Daniel, et al.
Publicado: (2019)

Palliative pelvic radiotherapy of symptomatic incurable rectal cancer – a systematic review
por: Cameron, Marte Grønlie, et al.
Publicado: (2014)

Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer
por: Vesa, Väliaho, et al.
Publicado: (2023)

Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer
por: Koeberle, D, et al.
Publicado: (2008)

Dosimetric Comparative Study of 3 Different Postoperative Radiotherapy Techniques (3D-CRT, IMRT, and RapidArc) for II–III Stage Rectal Cancer
por: Liu, Min, et al.
Publicado: (2015)

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
por: Taal, B G, et al.
Publicado: (2001)

Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II–IV rectal cancer
por: Wu, Yinying, et al.
Publicado: (2017)

Pelvic exenteration with en bloc resection of the pelvic sidewall and intraoperative electron beam radiotherapy with Mobetron(®) for locally advanced rectal cancer
por: Rangarajan, K., et al.
Publicado: (2017)

Which Definition of Upper Rectal Cancer Is Optimal in Selecting Stage II or III Rectal Cancer Patients to Avoid Postoperative Adjuvant Radiation?
por: Gao, Xian Hua, et al.
Publicado: (2021)

Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer of Patients with Prior Pelvic Irradiation
por: Yamada, Shigeru, et al.
Publicado: (2021)

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer
por: Sarasqueta, C., et al.
Publicado: (2019)

Pelvic insufficiency fractures, dose volume parameters and plan optimization after radiotherapy for rectal cancer
por: Kronborg, Camilla J.S., et al.
Publicado: (2019)

Tumour regression in the randomized Stockholm III Trial of radiotherapy regimens for rectal cancer
por: Pettersson, D., et al.
Publicado: (2015)

A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer
por: Chan, Jason, et al.
Publicado: (2013)

Radiotherapy for stage IIA rectal cancer may not benefit all
por: Hu, Xiang, et al.
Publicado: (2017)

Oncologic Outcomes of Postoperative Chemoradiotherapy Versus Chemotherapy Alone in Stage II and III Upper Rectal Cancer
por: Yoon, Ji Eun, et al.
Publicado: (2019)

Incremental Value of Radiomics in 5-Year Overall Survival Prediction for Stage II–III Rectal Cancer
por: Nie, Ke, et al.
Publicado: (2022)

The Conditioning of Adjuvant Chemotherapy for Stage II and III Rectal Cancer Determined by Postoperative Pathological Characteristics in Romania
por: Liscu, Horia-Dan, et al.
Publicado: (2023)

Utility of Restaging MRI Following Neoadjuvant Chemoradiotherapy for Stage II-III Rectal Adenocarcinoma
por: Aryan, Mahmoud, et al.
Publicado: (2021)

The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
por: Kim, Jun Won, et al.
Publicado: (2010)

ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy
por: Deng, Y, et al.
Publicado: (2014)

Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study
por: Cai, Gang, et al.
Publicado: (2014)

Effect of Abdominal Circumference on the Irradiated Bowel Volume in Pelvic Radiotherapy for Rectal Cancer Patients: Implications for the Radiotherapy-Related Intestinal Toxicity
por: Wang, Gang, et al.
Publicado: (2022)

Mesorectal radiotherapy for early stage rectal cancer: A novel target volume
por: Peters, Femke P., et al.
Publicado: (2020)

Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III
por: Oblak, Irena, et al.
Publicado: (2011)

Prophylactic lateral pelvic lymph node dissection in stage IV low rectal cancer
por: Tamura, Hiroshi, et al.
Publicado: (2017)

Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study
por: Kang, Yu‐Mei, et al.
Publicado: (2019)

Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid–upper rectal cancer
por: Choi, Seo Hee, et al.
Publicado: (2017)

Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer
por: Sarasqueta, Cristina, et al.
Publicado: (2020)

The number of cycles of adjuvant chemotherapy in stage III and high-risk stage II rectal cancer: a nomogram and recursive partitioning analysis
por: Chen, Wei-Wei, et al.
Publicado: (2022)

Selected stage IV rectal cancer patients managed by the watch‐and‐wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
por: Custers, Petra A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rdnkim1iv31bng0vmcpmajnpkg